Corporate Governance

Sarah Downey, president and CEO at Michael Garron Hospital, has written a letter to EllisDon's CEO after a third incidence of anti-Black racism took place on the EllisDon construction site in a four-month period. The incidents happened on the site where a hospital extension is being built at the Michael Garron Hospital in East York, a suburb of Toronto.

The college said information within health banks in clinical fields should not be allowed to be communicated to third parties for research or statistical purposes without the patient's consent.

Last week, Quebec's government ordered an inquiry into the death of Joyce Echaquan, an Indigenous woman from Manawan who recorded workers at the Centre hospitalier de Lanaudière in Joliette mocking her with sexist and racist abuse soon before she died.

The goal here is not to admonish Canada’s most revered medical organizations, but rather to illustrate the historic and longstanding dearth of Black representation in Canadian medical leadership. Over the past few years, calls to address barriers to achieving diversity in the Canadian health workforce have been gaining momentum. Diversity exists along a broad spectrum that includes gender, socioeconomic, linguistic, and racial subsets, to mention a few. Acknowledging that there exist many populations that are also underrepresented in the highest echelons of Canadian medical leadership, this article speaks specifically to the paucity of Black Canadians in formal physician leadership roles while proposing four key recommendations for addressing this diversity gap.

Started in 2015, the network of pharmacies is spread out across the country in every province except Quebec and Nova Scotia.

Dr. Meili noted the funding commitment would be enough to hire 100 doctors, 150 registered nurses, 300 licensed practical nurses and 500 clinical care assistance, as one example of how it could be distributed.

Just halfway through a five-year agreement between the pan-Canadian Pharmaceutical (pCPA) Alliance and the Canadian Generic Pharmaceutical Association (CGPA), the deal has produced $2 billion in savings.

Dr. Howard is also a clinical associate professor at the Cumming School of Medicine at the University of Calgary.